The Natural Killer T (NKT) Cell Ligand α-Galactosylceramide Demonstrates Its Immunopotentiating Effect by Inducing Interleukin (IL)-12 Production by Dendritic Cells and IL-12 Receptor Expression on NKT Cells

Hidemitsu Kitamura, Kenji Iwakabe, Takashi Yahata, +10

The Journal of Experimental Medicine

IL-6 Regulates In Vivo Dendritic Cell Differentiation through STAT3 Activation

Sung-Joo Park, Takayuki Nakagawa, Hidemitsu Kitamura, +9

The Journal of Immunology

Toll-like receptor–mediated regulation of zinc homeostasis influences dendritic cell function

Hidemitsu Kitamura, Hideyuki Morikawa, Hokuto Kamon, +8

Nature Immunology

InflammationToll-like ReceptorsMolecular ImmunologyInnate Immune SystemImmunology +11

Local Radiation Therapy Inhibits Tumor Growth through the Generation of Tumor-Specific CTL: Its Potentiation by Combination with Th1 Cell Therapy

Tsuguhide Takeshima, Kenji Chamoto, Daiko Wakita, +5

Cancer Research

Adaptive RadiotherapyRadiation MedicineTherapeutic EffectCancer ImmunosurveillanceRadiation Therapy +13

Tumor‐infiltrating IL‐17‐producing γδ T cells support the progression of tumor by promoting angiogenesis

Daiko Wakita, Kentaro Sumida, Yoichiro Iwakura, +5

European Journal of Immunology

T-regulatory CellImmunologyImmune RegulationImmunologic MechanismCd4 T Cell Responses +16

IL-6-STAT3 Controls Intracellular MHC Class II αβ Dimer Level through Cathepsin S Activity in Dendritic Cells

Hidemitsu Kitamura, Hokuto Kamon, Shin-ichiro Sawa, +5

Immunity

InflammationCytokineCathepsin S ActivityImmune RegulationImmunology +6

IL-6–dependent spontaneous proliferation is required for the induction of colitogenic IL-17–producing CD8+ T cells

Masaki Tajima, Daiko Wakita, Daisuke Noguchi, +7

The Journal of Experimental Medicine

α-Galactosylceramide Induces Early B-Cell Activation through IL-4 Production by NKT Cells

Hidemitsu Kitamura, Akio Ohta, Masashi Sekimoto, +10

Cellular Immunology

Inflammationα-Galactosylceramide InducesCytokineImmune Cell DevelopmentImmune Regulation +10

Zinc Is Required for FcεRI-Mediated Mast Cell Activation

Koki Kabu, Satoru Yamasaki, Daisuke Kamimura, +6

The Journal of Immunology

Anti‐<scp>IL</scp>‐6 receptor m<scp>A</scp>b eliminates myeloid‐derived suppressor cells and inhibits tumor growth by enhancing <scp>T</scp>‐cell responses

Kentaro Sumida, Daiko Wakita, Yoshinori Narita, +6

European Journal of Immunology

Imc SubsetsImmunologyImmune RegulationPathologyImmunoediting +20